Tuesday, June 25, 2024
Home Tags AD PD 2021

Tag: AD PD 2021

Lilly’s donanemab reduces Alzheimer’s disease progression in Phase 2 trial

ALZ results revealed by Eli Lilly and Company at the recent 15th International Conference on Alzheimer's & Parkinson Diseases 2021 (AD/PD 2021) expand on...